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Background: The angiotensin converting enzyme 2 (ACE2) G8790A gene polymorphism
has been associated with the susceptibility to essential hypertension (EH), but the results
are disputable. Objective and Methods:To investigate the relationship between the ACE2
G8790A gene polymorphism and EH, eight separate studies with 5260 subjects were
meta-analyzed. The pooled odds ratio (OR) and its corresponding 95% confidence interval
(CI) were calculated by a random effect model. Results: In the ACE2 G8790A gene poly-
morphism and EH meta-analysis in a Chinese population, no significant association was
found between the ACE2 G8790A gene polymorphism and EH (OR: 1.03, 95% CI: 0.87–
1.21, P =0.76). In the stratified analysis by gender, no significant risk was found among
males (OR: 1.06, 95% CI: 0.82–1.36, P =0.66) or females (OR: 0.98, 95% CI: 0.77–1.24,
P =0.85). Under a dominant model of inheritance in the female subgroup, the pooled OR
for the GG/GA+AA value was 1.01 (95% CI: 0.82–1.25, P = 0.92). Under a recessive model
of inheritance in the female subgroup, the pooled OR for the AA/AG+GG value was 0.93
(95% CI: 0.50–1.73, P =0.83). Conclusion: The current meta-analysis suggested that the
ACE2 G8790A gene polymorphism might not be related to the increased EH risk in the
Chinese population.
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INTRODUCTION
The gene polymorphism of angiotensin converting enzyme 2
(ACE2) has been associated with the pathogenesis of essential
hypertension (EH). ACE2, a homolog of ACE discovered by
Donoghue et al. (2000) and Tipnis et al. (2000), has a catalytic
domain 42% similar with that of ACE. ACE2 is mainly expressed
in the kidney, but is also found in the heart, testes, blood ves-
sels, lungs, brain, nose, mouth, gastrointestinal tissues, and so on.
In contrast to ACE, ACE2 is not obviously expressed in any of
these tissues, but is mostly expressed in endothelial cells. ACE2 is
located in the Xp22 chromosome with 18 exons. ACE2 hydrolyzes
angiotensin (Ang) I and generates Ang 1–9. Ang 1–9 is resolved
into Ang 1–7, whose physiological activities are contrary to Ang II.
Ang 1–7 can relax vessels, decrease the blood pressure, as well as
inhibit the proliferation of cardiac myocytes, myocardium fibrob-
lasts, and vascular smooth muscle cells. Hence, ACE2 and ACE
exhibit mutual antagonism. ACE2 is supposed to demonstrate a
protective function in the regulation of heart and blood pres-
sures. Consequently, ACE2 may become a new treatment target
for cardiovascular diseases.
Angiotensin converting enzyme 2 gene, located in X chromo-
some, spans ∼2.4 kb and contains 18 exons. The G8790A poly-
morphism was at fourth base in the third intron adjacent to exon.
The 8790th base guanine (G) was substituted by adenine (A) which
resulted in the mRNA montage changes andACE2 gene expression.
The association of the ACE2 G8790A gene polymorphism with
EH significantly differed among various ethnicities. Benjafield
et al. (2004) have found no association between theACE2 G8790A
gene polymorphism and EH in Australian individuals by a poly-
merase chain reaction-restriction fragment length polymorphism
analysis (Benjafield et al., 2004). Zhong et al. (2006) have found
that females and individuals carrying only the G allele had signif-
icantly higher risks for increased diastolic blood pressure (DBP).
The ACE2 G8790A polymorphism is also concluded to be asso-
ciated with hypertension in Han-Chinese patients with metabolic
syndromes (Zhong et al., 2006). Jiang et al. (2010) found that the
ACE2 G8790A polymorphism might be associated with EH. They
reported that male populations with G allele and female popula-
tion with GG genotype had higher risk of EH in China (Jiang et al.,
2010). However, Si et al. (2009) reported that the A allele increased
the EH risk only in the male Chinese population. They found no
significant association of ACE2 G8790A gene polymorphism and
EH in the female Chinese population. Zhou and Yang (2009) per-
formed a meta-analysis on the ACE2 G8790A polymorphism with
Chinese Han EH and they concluded thatACE2 G8790A polymor-
phism might not be genetic risk factor for EH in a Chinese Han
population. In contrast, Lu et al. (2012) also conducted a similar
meta-analysis and they found that ACE2 G8790A polymorphism
was probably a genetic risk factor for EH across different ethnic
populations in female subjects and in Han-Chinese male subjects.
The present meta-analysis, which involved 5260 participants,
was performed to obtain a more precise and comprehensive
estimation of the association between the ACE2 G8790A gene
polymorphism and EH in the Chinese population.
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MATERIALS AND METHODS
PUBLICATION SEARCH AND INCLUSION CRITERIA
The electronic databases PubMed, Embase, Web of Science, China
Biological Medicine Database, and China National Knowledge
Infrastructure were searched in the current meta-analysis using the
medical subject heading “hypertension,” “ACE2,” and “gene poly-
morphism.” The last research was performed on July 23, 2012. The
range of publication years was from 2005 to 2010.
The inclusion criteria were as follow: (a) evaluation of the
association between the ACE2 G8790A gene polymorphism and
EH; and (b) the EH diagnosis was in line with the 1999 EH
diagnosis criteria of the World Health Organization as systolic
blood pressure (SBP) ≥140 mmHg, DBP ≥90 mmHg. Secondary
hypertension was not included in the present investigation.
DATA EXTRACTION
Data were collected according to a standard protocol. Repeated
publications, those that violate any inclusion criterion, and/or
those deviating from the Hardy–Weinberg equilibrium (HWE)
were excluded. If different articles conveyed the same results, the
results were considered only once in the current meta-analysis.
The information extracted from literature included the name of
the first author, year of publication, region, number of genotypes,
total number of cases, and controls listed in Tables S1 and S2 in
Supplementary Material. Given thatACE2 is located in the X chro-
mosome, the meta-analysis was classified into male and female
subgroups.
STATISTICAL METHODS
The strength of association between the ACE2 G8790A gene
polymorphism and EH was assessed by the odds ratio (OR)
corresponding to a 95% confidence interval (CI). The chi-square-
based Q-test was used to check the heterogeneity assumption
(significance set at P < 0.05; Cochran, 1968). Upon determina-
tion of heterogeneity among studies, the random-effects model
was used to estimate the pooled OR by the DerSimonian and
Laird method (DerSimonian and Laird, 1986). Otherwise, the
pooled OR was estimated using the fixed-effects model (the
Mantel–Haenszel method; Mantel and Haenszel, 1959). I 2 was
used to assess the heterogeneity. The lower was the I 2, the
smaller was the heterogeneity. Fisher’s exact test was used to
assess the HWE (significance set at P < 0.05). The potential pub-
lication bias was estimated by the funnel plot. Egger et al.’s
(1997) linear regression test of the natural logarithm scale of
the OR (significance set at P < 0.05) was used to assess the
funnel plot asymmetry. The STATA 10.0 software (StataCorp,
College Station, TX, USA) was used to perform all statistical
analyses.
FIGURE 1 | Flow diagram of articles selection process forACE2 G8790A gene polymorphism and EH risk meta-analysis.
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RESULTS
STUDY CHARACTERISTICS AND META-ANALYSIS RESULTS
A total of 15 papers were retrieved by the literature search, and
eight of the papers fitted the study selection criteria. Of the seven
excluded studies, three papers were reviews, three had nothing
about the ACE 2 G8790A gene polymorphism, and one was a
repeated publication (Zhang et al., 2008). In the female subgroup,
four papers deviating from the HWE were excluded (Liu et al.,
2005; Niu et al., 2007; Si et al., 2009; Zhang et al., 2010; Figure 1).
In total, the data from the eight studies were gathered from 3090
men and 2170 women from three ethnicities. There were 2769
EH patients and 2491 controls. In the male subgroup, there were
1670 EH patients and 1420 controls. In the female subgroup, there
were 1099 EH patients and 1071 controls. The OR values differed
among the eight studies, and some of which approved that the A
allele of G8790A increased the EH risk. However, the results of
other studies were unclear and had to be integrated to reach a
valuable conclusion. The three ethnicities included Han, Dongxi-
ang and Li (Tables S1 and S2 in Supplementary Material; Liu et al.,
2005; Hang et al., 2006; Yi et al., 2006; Fan et al., 2007; Niu et al.,
2007; Si et al., 2009; Jiang et al., 2010; Zhang et al., 2010).
In the present ACE2 G8790A gene polymorphism and EH
meta-analysis, under an allelic genetic model of inheritance, the
distribution of the A allelic frequency was 0.496 for the EH group
and 0.489 for the control. Figure 2 shows the summary OR of the
distribution of the A allelic frequency, which was 1.03 (95% CI:
0.87–1.21) by the random effects model. The heterogeneity com-
parisons significantly differed (P = 0.003, I 2= 61.0%), but the EH
and control groups did not (P = 0.76; Table 1; Figure 2).
The summary OR of the distribution frequency of the A allele
in the male subgroup was 1.06 (95% CI: 0.82–1.36), as shown in
Figure 2. In this subgroup, the distribution of the A allelic fre-
quency was 0.469 for the EH group and 0.449 for the control.
The heterogeneity among the eight studies significantly differed
(P = 0.01, I 2= 61.0%), but the EH and control groups did not
(P = 0.66; Table 1; Figure 2).
The summary OR of the distribution frequency of the A allele
in the female subgroup was 0.98 (95% CI: 0.77–1.24), as shown
in Figure 2. In this subgroup, the distribution of the A allelic fre-
quency was 0.516 for the EH group and 0.516 for the control. The
heterogeneity among the four studies also significantly differed
(P = 0.02, I 2= 69.2%), but the EH and control groups did not
(P = 0.85; Table 1; Figure 2).
Under a dominant model of inheritance in the female subgroup,
the GG/GA+AA value was 0.317 for the EH group and 0.314 for
the control. The pooled OR for the GG/GA+AA value was 1.01
(95% CI: 0.82–1.25, Pheterogeneity= 0.11, I 2= 50.7%). The associ-
ation between the ACE2 G8790A gene polymorphism and EH in
the women was not significant (P = 0.92; Figure 3; Table 1).
Under a recessive model of inheritance in the female sub-
group, the AA/AG+GG value was 0.375 for the EH group and
0.373 for the control. The pooled OR for the AA/AG+GG value
FIGURE 2 | Forest plot of EH associated with ACE2 G8790A gene polymorphism under an allelic genetic model stratified by gender (distribution of A
allelic frequency of ACE2 gene).
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was 0.93 (95% CI: 0.50–1.73, Pheterogeneity= 0.0001, I 2= 85.5%).
There was no significant association between the ACE2 G8790A
gene polymorphism and EH in the women (P = 0.83; Figure 4;
Table 1).
Meta-regression was conducted to explore the potential sources
of heterogeneity in the male subgroup under the allelic genetic
model of inheritance. The confounding factors included the pub-
lication year, study region, ethnicity, G genotype number of EH
group sample size (G1), and G genotype number of control group
sample size (G0). All these confounding factors could explain
the heterogeneity (P < 0.05), but publication year was the most
important (P = 0.017; Table 2).
In the subsection analysis stratified by the publication year,
Subsection 1 was defined as publication year ranging from 2005
to 2007. Studies with publication year ranging from 2009 to 2010
were defined as Subsection 2. In Subsection one of five studies,
the pooled OR was 1.16 (95% CI: 0.95–1.40, Pheterogeneity= 0.20,
I 2= 33.8%). In Subsection 2 of three studies, the pooled OR was
0.74 (95% CI: 0.31–1.79, Pheterogeneity= 0.02, I 2= 74.9%). The
subsection analysis indicated that the heterogeneity in Subsec-
tion 2 was higher than that in Subsection 1. Therefore, studies on
Subsection 2 need further improvement (Table 3; Figure 5).
Table 1 | Summary of meta-analysis of association ofACE2 G8790A
gene polymorphism and EH risk in the Chinese population.
Gender Pooled OR (95% CI) Z (P ) I2 (%)
Allelic genetic model 1.03 (0.87–1.21) 0.31 (P = 0.76) 61.0
Male subgroup 1.06 (0.82–1.36) 0.44 (P = 0.66) 61.0
Female subgroup 0.98 (0.77–1.24) 0.18 (P = 0.85) 69.2
Dominant genetic
model for female
1.01 (0.82–1.25) 0.10 (P = 0.92) 50.7
Recessive genetic
model for female
0.93 (0.501–1.73) 0.22 (P = 0.83) 85.5
CI, confidence interval; OR, odds ratio; Allelic genetic model: distribution of A
allelic frequency of ACE2 gene; Dominant genetic model: GG/GA+AA; Recessive
genetic model: AA/GA+GG.
BIAS DIAGNOSTICS
No visual evidence of publication bias was found from the fun-
nel plot (Figure 6). There was also no significant difference in the
Egger’s test under the allelic genetic model, which implied that the
publication bias was low in the current meta-analysis (P = 0.658,
T = 0.46).
DISCUSSION
Essential hypertension is a complex disease caused by a com-
bination of genetic and environmental factors. Crackower et al.
(2002) have found that although the gene knockout of ACE2 does
not affect blood pressure regulation, the serum Ang II level sig-
nificantly increases. The cardiovascular and renal effects of Ang
II are the most important long-term blood pressure regulation
mechanisms. They have also found that ACE2 knockout mice
exhibit the cardiac abnormalities similar with cardiac stunning
in humans.
The G8790A gene polymorphism of ACE2 is the restriction
enzyme cutting site located on the fourth base of the third intron.
The code is ranked as rs2285666 in the United States Biotechnology
Information Center. mRNA and protein expression levels change
in cardiovascular diseases and diabetes mellitus (DM; Ribeiro-
Oliveira et al., 2008). Hence, the G8790A gene polymorphism may
participate in the onset of such illnesses as hypertension, cardiac
dysfunction, and DM. The G8790A gene polymorphism is situ-
ated in the intron adjoined to the extron, suggesting that this locus
could alter mRNA alternate splicing and affect ACE2 gene expres-
sion. The latter led to changes in the serum content of Ang 1–7
that inhibited vasoconstriction and cell proliferation (Kramkowski
et al., 2006).
Given the location of the ACE2 gene in X chromosomes,
the association of the G8790A gene polymorphism and EH was
classified and analyzed according to gender. In the present meta-
analysis, under the premise that age and gender factors were
controlled, no significant association was found between theACE2
G8790A gene polymorphism and EH under allelic, dominant,
and recessive genetic models. There was no significant difference
between the EH and control groups in either male or female sub-
groups. The current meta-analysis suggested that the A allele of
FIGURE 3 | Forest plot of the dominant genetic model of EH associated withACE2 G8790A gene polymorphism in female population (GG/GA+AA
value of angiotensin converting enzyme 2 gene).
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FIGURE 4 | Forest plot of the recessive genetic model of essential hypertension associated withACE2 G8790A gene polymorphism in female
population (AA/GA+GG value of angiotensin converting enzyme 2 gene).
Table 2 |The meta-regression results among eight studies in the male subgroup under the allelic genetic model.
Item Coefficient Standard error T value P value 95% Confidence interval
Weight −0.1845581 0.014793 −12.48 0.051 −0.3725206 to 0.0034044
Publication year −0.5106332 0.0132544 −38.53 0.017* −0.6790462 to −0.3422202
Region −0.8178791 0.0265906 −30.76 0.021* −1.155745 to −0.480013
G genotype number of EH group size 0.0111473 0.0005284 21.10 0.030* 0.0044336 to 0.017861
Ethnicity −0.3915033 0.0197832 −19.79 0.032* −0.6428729 to −0.1401337
G genotype number of control group size −0.0156601 0.0007113 −22.02 0.029* −0.0246984 to −0.0066219
Cons 1028.613 26.69087 38.54 0.017 689.4735 to 1367.753
*P < 0.05.
Coefficient: regression coefficient.
The regression coefficients are the estimated increase in the lnOR per unit increase in the covariates. Cons, constant item.
Table 3 | Subsection analysis summary of the allelic genetic model stratified by publication year in the male subgroup.
Subsection Studies number Weight (%) Pooled OR (95% CI) Z (P ) I2 (%)
Subsection 1 5 77.46 1.16 (0.95–1.40) 1.47 (P = 0.14) 33.8
Subsection 2 3 22.54 0.74 (0.31–1.79) 0.66 (P = 0.51) 74.9
Whole population 8 100.0 1.06 (0.82–1.36) 0.44 (P = 0.66) 61.0
Subsection 1: published before 2007.
Subsection 2: published after 2009.
the ACE2 G8790A gene polymorphism might not be related to
increased risk for EH.
In the meta-regression of the confounding factor, the publi-
cation year was considered as the most important heterogeneity
source. The publication year before 2007 indicated lower het-
erogeneity, and suggested that the early studies have the smaller
heterogeneity than the latter studies.
The results of the current research conformed to those of
Zhou and Yang (2009) who meta-analyzed theACE2 G8790A gene
polymorphism and EH in a Chinese Han population. The ACE2
G8790A gene polymorphism might not be a genetic risk factor for
EH in the said population. However, not all of the included studies
have followed the HWE. For instance, the study of Liu et al. (2005)
has deviated from the HWE. Hence, this study was excluded in the
current meta-analysis. In addition, three genetic models, namely,
allelic, dominant, and recessive genetic models, were adopted in
the present study to analyze the research results. In contrast, only
the allelic genetic model was used in Zhou’s work. Regarding Lu’s
et al. (2012) work, the limitation also existed. The studies against
HWE were also included in the female subgroup in their meta-
analysis (Liu et al., 2005; Niu et al., 2007; Si et al., 2009; Zhang
et al., 2010). Moreover, another included study was not associated
with EH but orthostatic hypertension (Fan et al., 2009). Given
these limitations, Lu’s conclusion seemed not credible.
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FIGURE 5 | Forest plot of EH associated withACE2 G8790A gene polymorphism stratified by publication year in male subgroup (distribution of A
allelic frequency ofACE2 gene).
FIGURE 6 | Funnel plot for studies of the association of essential
hypertension and ACE2 G8790A gene polymorphism (distribution of A
allelic frequency ofACE2 gene). The horizontal and vertical axis correspond
to the OR and confidence limits. OR, odds ratio; SE, standard error.
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In conclusion, the current meta-analysis suggested that the
ACE2 G8790A gene polymorphism was not associated with sus-
ceptibility to EH in the Chinese population. Further studies should
use higher investigation sample sizes. Given the relatively small
sample size used in the present study, further research should be
performed to test the abovementioned conclusion.
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